Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Summary
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and ...
Description
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source